Veoza vs HRT: Tracking Guide for Comparing Treatment Options
How to track symptoms and treatment response when comparing Veoza (fezolinetant) and hormone replacement therapy for menopause hot flashes.
Choosing between Veoza (fezolinetant) and hormone replacement therapy (HRT) is a personal decision made with your physician. Tracking your symptoms helps inform that conversation with real data about your experience.
Key differences at a glance
Veoza (fezolinetant):
- Non-hormonal treatment
- Targets hot flashes specifically
- Once-daily pill
- Requires liver monitoring
- FDA approved 2023
Hormone Replacement Therapy:
- Replaces declining hormones
- Addresses multiple menopause symptoms
- Various forms (pills, patches, gels, rings)
- Individualized dosing
- Long-established track record
What to track when comparing options
If you're considering both treatments
Before your physician visit, track these baseline metrics:
- Hot flash frequency: Episodes per day/week
- Hot flash severity: Consistent 1-5 scale
- Sleep disruption: Wake-ups, quality rating
- Other symptoms: Mood, vaginal dryness, joint pain
- Current medications: Complete list
If you're switching treatments
When transitioning between treatments, track:
- Washout period symptoms (if applicable)
- Time to notice changes with new treatment
- Side effects specific to new medication
- Symptoms that improve, worsen, or stay same
- Overall quality of life rating
Tracking template: decision data
Week-by-week comparison journal
Week 1-2:
- Daily hot flash count: ___
- Worst severity this week: ___
- Sleep quality (1-10): ___
- Side effects noted: ___
Week 3-4:
- Daily hot flash count: ___
- Average severity: ___
- Sleep quality (1-10): ___
- New symptoms or changes: ___
Questions to answer with your data
For Veoza consideration
- Are hot flashes my primary concern?
- Do I have contraindications to hormone therapy?
- What's my current hot flash frequency baseline?
- Am I comfortable with required liver monitoring?
For HRT consideration
- Do I have multiple menopause symptoms?
- What symptoms beyond hot flashes affect my quality of life?
- Have I tracked which symptoms are most disruptive?
- What are my personal risk factors to discuss?
Preparing for your physician conversation
Bring organized data showing:
- Hot flash baseline: 2-week minimum of frequency and severity
- Symptom inventory: All menopause-related symptoms with severity ratings
- Quality of life impact: How symptoms affect daily function
- Treatment preferences: Any concerns about specific approaches
- Medical history: Relevant for risk assessment
What tracking reveals that matters
Your personal data can show:
- Symptom patterns: Are hot flashes the main issue or one of many?
- Severity impact: How much do symptoms affect your daily life?
- Timing patterns: Are symptoms consistent or cyclical?
- Treatment priorities: What matters most to address first?
Frequently asked questions
Can I try both treatments?
Your physician can discuss sequencing or, in some cases, combining approaches. Tracking data helps assess whether changes help.
How long should I track before deciding?
A minimum of 2 weeks of baseline data gives your physician useful information. Longer tracking (4+ weeks) reveals patterns.
What if one treatment doesn't work?
Tracking helps identify when a treatment isn't providing adequate relief. Data showing persistent symptoms supports conversations about adjustments or alternatives.
What this page is / is not
This page helps you track symptoms to inform treatment discussions with your physician. It does not recommend one treatment over another or provide medical advice.